Market Cap : 4.92 B | Enterprise Value : 4.79 B | P/E (TTM) : | P/B : 39.75 |
---|
NAS:EIDX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:EIDX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Eidos Therapeutics's enterprise value is $4,790.56 Mil. Eidos Therapeutics's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 was $0.13 Mil. Therefore, Eidos Therapeutics's EV-to-Revenue for today is 37,720.96.
During the past 4 years, the highest EV-to-Revenue of Eidos Therapeutics was 38782.40. The lowest was 45.30. And the median was 65.85.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2021-01-18), Eidos Therapeutics's stock price is $126.510000. Eidos Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $0.00. Therefore, Eidos Therapeutics's PS Ratio for today is 42,170.00.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Eidos Therapeutics's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Eidos Therapeutics's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 4790.562 | / | 0.127 | |
= | 37,720.96 |
Eidos Therapeutics's current Enterprise Value is $4,790.56 Mil.
Eidos Therapeutics's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 was 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0.127 (Sep. 2020 ) = $0.13 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Eidos Therapeutics's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 126.510000 | / | 0.003 | |
= | 42,170.00 |
Eidos Therapeutics's share price for today is $126.510000.
Eidos Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0.003 (Sep. 2020 ) = $0.00.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline